Table of Contents
Global Vasculitis Drug Market Research Report 2021
1 Vasculitis Drug Market Overview
1.1 Product Overview and Scope of Vasculitis Drug
1.2 Vasculitis Drug Segment by Type (Product Category)
1.2.1 Global Vasculitis Drug Production and CAGR (%) Comparison by Type (Product Category)(2016 - 2027)
1.2.2 Global Vasculitis Drug Production Market Share by Type (Product Category) in 2017
1.2.3 Blisibimod
1.2.4 CCX - 168
1.2.5 Gevokizumab
1.2.6 Rituximab Biosimilar
1.2.7 Others
1.3 Global Vasculitis Drug Segment by Application
1.3.1 Vasculitis Drug Consumption (Sales) Comparison by Application (2016 - 2027)
1.3.2 Polyarteritis Nodosa
1.3.3 Thrombotic Vasculitis
1.3.4 Granulomatous Vasculitis
1.3.5 Lymphocytic Vasculitis
1.3.6 Others
1.4 Global Vasculitis Drug Market by Region (2016 - 2027)
1.4.1 Global Vasculitis Drug Market Size (Value) and CAGR (%) Comparison by Region (2016 - 2027)
1.4.2 North America Status and Prospect (2016 - 2027)
1.4.3 Europe Status and Prospect (2016 - 2027)
1.4.4 China Status and Prospect (2016 - 2027)
1.4.5 Japan Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Status and Prospect (2016 - 2027)
1.4.7 India Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value) of Vasculitis Drug (2016 - 2027)
1.5.1 Global Vasculitis Drug Revenue Status and Outlook (2016 - 2027)
1.5.2 Global Vasculitis Drug Capacity, Production Status and Outlook (2016 - 2027)
2 Global Vasculitis Drug Market Competition by Manufacturers
2.1 Global Vasculitis Drug Capacity, Production and Share by Manufacturers (2016 - 2021)
2.1.1 Global Vasculitis Drug Capacity and Share by Manufacturers (2016 - 2021)
2.1.2 Global Vasculitis Drug Production and Share by Manufacturers (2016 - 2021)
2.2 Global Vasculitis Drug Revenue and Share by Manufacturers (2016 - 2021)
2.3 Global Vasculitis Drug Average Price by Manufacturers (2016 - 2021)
2.4 Manufacturers Vasculitis Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Vasculitis Drug Market Competitive Situation and Trends
2.5.1 Vasculitis Drug Market Concentration Rate
2.5.2 Vasculitis Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Vasculitis Drug Capacity, Production, Revenue (Value) by Region (2016 - 2021)
3.1 Global Vasculitis Drug Capacity and Market Share by Region (2016 - 2021)
3.2 Global Vasculitis Drug Production and Market Share by Region (2016 - 2021)
3.3 Global Vasculitis Drug Revenue (Value) and Market Share by Region (2016 - 2021)
3.4 Global Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.5 North America Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.6 Europe Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.7 China Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.8 Japan Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.9 Southeast Asia Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.10 India Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
4 Global Vasculitis Drug Supply (Production), Consumption, Export, Import by Region (2016 - 2021)
4.1 Global Vasculitis Drug Consumption by Region (2016 - 2021)
4.2 North America Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
4.3 Europe Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
4.4 China Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
4.5 Japan Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
4.6 Southeast Asia Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
4.7 India Vasculitis Drug Production, Consumption, Export, Import (2016 - 2021)
5 Global Vasculitis Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Vasculitis Drug Production and Market Share by Type (2016 - 2021)
5.2 Global Vasculitis Drug Revenue and Market Share by Type (2016 - 2021)
5.3 Global Vasculitis Drug Price by Type (2016 - 2021)
5.4 Global Vasculitis Drug Production Growth by Type (2016 - 2021)
6 Global Vasculitis Drug Market Analysis by Application
6.1 Global Vasculitis Drug Consumption and Market Share by Application (2016 - 2021)
6.2 Global Vasculitis Drug Consumption Growth Rate by Application (2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Vasculitis Drug Manufacturers Profiles/Analysis
7.1 Merck
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Vasculitis Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Merck Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Vasculitis Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Farmalider
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Vasculitis Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Farmalider Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Hainan Pharmaceutical Factory
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Vasculitis Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Hainan Pharmaceutical Factory Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Shanghaihuangxiang Lantian Pharmaceutical
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Vasculitis Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2015 - 2021)
7.5.4 Main Business/Business Overview
7.6 Huzhou Konch Pharmaceutical
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Vasculitis Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Huzhou Konch Pharmaceutical Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 CSPC Ouyi Pharmaceutical
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Vasculitis Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Sino - US Zibo Xinhua - Perrigo Pharmaceutical
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Vasculitis Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Sino - US Zibo Xinhua - Perrigo Pharmaceutical Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Hubei Biocause Pharmaceutical
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Vasculitis Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Hubei Biocause Pharmaceutical Vasculitis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.9.4 Main Business/Business Overview
8 Vasculitis Drug Manufacturing Cost Analysis
8.1 Vasculitis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Vasculitis Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Vasculitis Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Vasculitis Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Vasculitis Drug Market Forecast (2021 - 2027)
12.1 Global Vasculitis Drug Capacity, Production, Revenue Forecast (2021 - 2027)
12.1.1 Global Vasculitis Drug Capacity, Production and Growth Rate Forecast (2021 - 2027)
12.1.2 Global Vasculitis Drug Revenue and Growth Rate Forecast (2021 - 2027)
12.1.3 Global Vasculitis Drug Price and Trend Forecast (2021 - 2027)
12.2 Global Vasculitis Drug Production, Consumption , Import and Export Forecast by Region (2021 - 2027)
12.2.1 North America Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.2 Europe Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.3 China Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.4 Japan Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.5 Southeast Asia Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.6 India Vasculitis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.3 Global Vasculitis Drug Production, Revenue and Price Forecast by Type (2021 - 2027)
12.4 Global Vasculitis Drug Consumption Forecast by Application (2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Vasculitis Drug
Figure Global Vasculitis Drug Production () and CAGR (%) Comparison by Types (Product Category) (2016 - 2027)
Figure Global Vasculitis Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Blisibimod
Table Major Manufacturers of Blisibimod
Figure Product Picture of CCX - 168
Table Major Manufacturers of CCX - 168
Figure Product Picture of Gevokizumab
Table Major Manufacturers of Gevokizumab
Figure Product Picture of Rituximab Biosimilar
Table Major Manufacturers of Rituximab Biosimilar
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Vasculitis Drug Consumption (K Pcs) by Applications (2016 - 2027)
Figure Global Vasculitis Drug Consumption Market Share by Applications in 2017
Figure Polyarteritis Nodosa Examples
Table Key Downstream Customer in Polyarteritis Nodosa
Figure Thrombotic Vasculitis Examples
Table Key Downstream Customer in Thrombotic Vasculitis
Figure Granulomatous Vasculitis Examples
Table Key Downstream Customer in Granulomatous Vasculitis
Figure Lymphocytic Vasculitis Examples
Table Key Downstream Customer in Lymphocytic Vasculitis
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Vasculitis Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2016 - 2027)
Figure North America Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Vasculitis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Vasculitis Drug Revenue (Million USD) Status and Outlook (2016 - 2027)
Figure Global Vasculitis Drug Capacity, Production (K Pcs) Status and Outlook (2016 - 2027)
Figure Global Vasculitis Drug Major Players Product Capacity (K Pcs) (2016 - 2021)
Table Global Vasculitis Drug Capacity (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Vasculitis Drug Capacity Market Share of Key Manufacturers (2016 - 2021)
Figure Global Vasculitis Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Vasculitis Drug Capacity (K Pcs) of Key Manufacturers in 2021
Figure Global Vasculitis Drug Major Players Product Production (K Pcs) (2016 - 2021)
Table Global Vasculitis Drug Production (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Vasculitis Drug Production Share by Manufacturers (2016 - 2021)
Figure 2017 Vasculitis Drug Production Share by Manufacturers
Figure 2017 Vasculitis Drug Production Share by Manufacturers
Figure Global Vasculitis Drug Major Players Product Revenue (Million USD) (2016 - 2021)
Table Global Vasculitis Drug Revenue (Million USD) by Manufacturers (2016 - 2021)
Table Global Vasculitis Drug Revenue Share by Manufacturers (2016 - 2021)
Table 2017 Global Vasculitis Drug Revenue Share by Manufacturers
Table 2021 Global Vasculitis Drug Revenue Share by Manufacturers
Table Global Market Vasculitis Drug Average Price (USD/Pcs) of Key Manufacturers (2016 - 2021)
Figure Global Market Vasculitis Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Vasculitis Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Vasculitis Drug Product Category
Figure Vasculitis Drug Market Share of Top 3 Manufacturers
Figure Vasculitis Drug Market Share of Top 5 Manufacturers
Table Global Vasculitis Drug Capacity (K Pcs) by Region (2016 - 2021)
Figure Global Vasculitis Drug Capacity Market Share by Region (2016 - 2021)
Figure Global Vasculitis Drug Capacity Market Share by Region (2016 - 2021)
Figure 2017 Global Vasculitis Drug Capacity Market Share by Region
Table Global Vasculitis Drug Production by Region (2016 - 2021)
Figure Global Vasculitis Drug Production (K Pcs) by Region (2016 - 2021)
Figure Global Vasculitis Drug Production Market Share by Region (2016 - 2021)
Figure 2017 Global Vasculitis Drug Production Market Share by Region
Table Global Vasculitis Drug Revenue (Million USD) by Region (2016 - 2021)
Table Global Vasculitis Drug Revenue Market Share by Region (2016 - 2021)
Figure Global Vasculitis Drug Revenue Market Share by Region (2016 - 2021)
Table 2017 Global Vasculitis Drug Revenue Market Share by Region
Figure Global Vasculitis Drug Capacity, Production (K Pcs) and Growth Rate (2016 - 2021)
Table Global Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table North America Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Europe Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Global Vasculitis Drug Consumption (K Pcs) Market by Region (2016 - 2021)
Table Global Vasculitis Drug Consumption Market Share by Region (2016 - 2021)
Figure Global Vasculitis Drug Consumption Market Share by Region (2016 - 2021)
Figure 2017 Global Vasculitis Drug Consumption (K Pcs) Market Share by Region
Table North America Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Europe Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table China Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Japan Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Southeast Asia Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table India Vasculitis Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Global Vasculitis Drug Production (K Pcs) by Type (2016 - 2021)
Table Global Vasculitis Drug Production Share by Type (2016 - 2021)
Figure Production Market Share of Vasculitis Drug by Type (2016 - 2021)
Figure 2017 Production Market Share of Vasculitis Drug by Type
Table Global Vasculitis Drug Revenue (Million USD) by Type (2016 - 2021)
Table Global Vasculitis Drug Revenue Share by Type (2016 - 2021)
Figure Production Revenue Share of Vasculitis Drug by Type (2016 - 2021)
Figure 2017 Revenue Market Share of Vasculitis Drug by Type
Table Global Vasculitis Drug Price (USD/Pcs) by Type (2016 - 2021)
Figure Global Vasculitis Drug Production Growth by Type (2016 - 2021)
Table Global Vasculitis Drug Consumption (K Pcs) by Application (2016 - 2021)
Table Global Vasculitis Drug Consumption Market Share by Application (2016 - 2021)
Figure Global Vasculitis Drug Consumption Market Share by Applications (2016 - 2021)
Figure Global Vasculitis Drug Consumption Market Share by Application in 2017
Table Global Vasculitis Drug Consumption Growth Rate by Application (2016 - 2021)
Figure Global Vasculitis Drug Consumption Growth Rate by Application (2016 - 2021)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Vasculitis Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (Merck) and Gross Margin (2016 - 2021)
Figure Merck Vasculitis Drug Production Growth Rate (2016 - 2021)
Figure Merck Vasculitis Drug Production Market Share (2016 - 2021)
Figure Merck Vasculitis Drug Revenue Market Share (2016 - 2021)
Table Bayer Basic Info
